Andrew C. Karlinski’s Chemed CHE Stock Holding History

Andrew C. Karlinski’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	275
2022 Q2	$0	Hold	1	–	–	﹤0.01%	342
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	277
2021 Q4	$1K	Buy	+1	New	+$480	﹤0.01%	189

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Andrew C. Karlinski's CHE Position: Q3 2022 in Review

Andrew C. Karlinski sold out of Chemed (CHE) in Q3 2022, closing a stake of 1 share.

Andrew C. Karlinski first reported a position in CHE in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

Andrew C. Karlinski reported no remaining Chemed position as of Q3 2022 after selling out during the quarter.
Andrew C. Karlinski sold 1 Chemed share in Q3 2022.
Andrew C. Karlinski first reported a position in Chemed in Q4 2021 and held it in 3 quarters.
Andrew C. Karlinski's Chemed position peaked at $1K in Q1 2022.
419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on Andrew C. Karlinski's 13F filing for Q3 2022, filed 14 Nov 2022.